| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 1.150.198.950 $ | -143.306.896 $ | -9,0 % | 1.471.489.648 $ | +363.373.580 $ | +41,5 % | 1.082.777.296 $ | +280.392.038 $ | +29,4 % | |
| FMR LLC | 357.226.003 $ | -75.576.129 $ | -17,5 % | 432.802.132 $ | +106.686.826 $ | +32,7 % | 326.115.306 $ | +154.222.504 $ | +89,7 % |
| BlackRock, Inc. | 145.388.755 $ | -35.267.406 $ | -19,5 % | 180.656.161 $ | +47.221.940 $ | +35,4 % | 133.434.221 $ | +25.140.182 $ | +23,2 % |
| RA CAPITAL MANAGEMENT, L.P. | 156.667.131 $ | -257.511 $ | -0,2 % | 156.924.642 $ | +52.709.478 $ | +50,6 % | 104.215.164 $ | +20.691.630 $ | +24,8 % |
| Atlas Venture Life Science Advisors, LLC | 96.797.168 $ | -23.419.646 $ | -19,5 % | 120.216.814 $ | -21.367.317 $ | -15,1 % | 141.584.131 $ | +15.303.341 $ | +12,1 % |
| VANGUARD GROUP INC | 140.371.470 $ | +44.683.732 $ | +46,7 % | 95.687.738 $ | +21.716.600 $ | +29,4 % | |||
| JPMORGAN CHASE & CO | 125.557.326 $ | +75.807.082 $ | +152,4 % | ||||||
| WELLINGTON MANAGEMENT GROUP LLP | 110.959.941 $ | -9.606.197 $ | -8,0 % | 120.566.138 $ | +27.388.251 $ | +29,4 % | 93.177.887 $ | +17.334.400 $ | +22,9 % |
| STATE STREET CORP | 108.585.721 $ | +14.247.356 $ | +15,1 % | 94.338.365 $ | +25.245.315 $ | +36,5 % | |||
| Frazier Life Sciences Management, L.P. | 86.629.237 $ | -13.427.363 $ | -13,4 % | 100.056.600 $ | +4.998.273 $ | +5,3 % | 95.058.327 $ | +7.418.318 $ | +8,5 % |
| ORBIMED ADVISORS LLC | 93.504.522 $ | +18.565.063 $ | +24,8 % | ||||||
| VANGUARD CAPITAL MANAGEMENT LLC | 87.944.994 $ | ||||||||
| 1.150.198.950 $ | -143.306.896 $ | -9,0 % | 1.471.489.648 $ | +363.373.580 $ | +41,5 % | 1.082.777.296 $ | +280.392.038 $ | +29,4 % | |